{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:15:19Z","timestamp":1791753319755,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2625,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.bbmt.2007.10.010","type":"journal-article","created":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T07:19:07Z","timestamp":1200899947000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Costs of Allogeneic Hematopoietic Cell Transplantation with High-Dose Regimens"],"prefix":"10.1016","volume":"14","author":[{"given":"Akiko M.","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zahrieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Soiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent T.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin P.","family":"Alyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Koreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2007.10.010_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"Thomas","year":"1957","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2007.10.010_bib2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","article-title":"Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation","volume":"102","author":"Mielcarek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.010_bib3","first-page":"3530","article-title":"Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation","volume":"27","author":"Sparrelid","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2007.10.010_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1086\/315435","article-title":"Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening","volume":"181","author":"Hebart","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2007.10.010_bib5","first-page":"583","article-title":"Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients","volume":"17","author":"Ljungman","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.010_bib6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1600-0463.2005.apm_336.x","article-title":"Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives","volume":"113","author":"Ringden","year":"2005","journal-title":"Apmis"},{"key":"10.1016\/j.bbmt.2007.10.010_bib7","series-title":"Thomas's Hematopoietic Cell Transplantation","first-page":"434","article-title":"Outcomes research in hematopoietic cell transplantation","author":"Lee","year":"2004"},{"key":"10.1016\/j.bbmt.2007.10.010_bib8","unstructured":"American Cancer Society. Cancer Facts & Figures 2006. Available at http:\/\/www.cancer.org\/docroot\/STT\/stt_0.asp Accessed March 21, 2007."},{"key":"10.1016\/j.bbmt.2007.10.010_bib9","unstructured":"Insurance and Transplant Coverage Information: National Marrow Donor Program. Available at http:\/\/www.marrow.org\/PATIENT\/Plan_for_Tx\/Planning_for_Tx_Costs\/Insurance_and_Transplant_Cover\/index.html. Accessed August 15, 2007."},{"key":"10.1016\/j.bbmt.2007.10.010_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bmt.1702845","article-title":"Non-HLA barriers to unrelated donor stem cell transplantation","volume":"27","author":"Kollman","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.010_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.bmt.1701065","article-title":"A detailed analysis of charges for hematopoietic stem cell transplantation at a children's hospital","volume":"21","author":"Kline","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.010_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1200\/JCO.2000.18.1.64","article-title":"Predicting costs of stem-cell transplantation","volume":"18","author":"Lee","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.10.010_bib13","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1097\/01.TP.0000129409.84087.62","article-title":"Predicting the costs of allogeneic sibling stem-cell transplantation: results from a prospective, multicenter, French study","volume":"77","author":"Esperou","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.10.010_bib14","first-page":"43","article-title":"Factors influencing third party payer costs for allogeneic BMT","volume":"12","author":"Griffiths","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.010_bib15","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bmt.1702681","article-title":"Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell Transplantation","volume":"26","author":"Matsuo","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.010_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/sj.bmt.1701949","article-title":"Costs of care associated with\u00a0high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995","volume":"24","author":"Freeman","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.010_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1200\/JCO.1995.13.4.969","article-title":"Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991","volume":"13","author":"Bennett","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.10.010_bib18","first-page":"190","article-title":"Asian Pacific cooperative study of allogeneic bone marrow transplantation","volume":"70","author":"Masaoka","year":"1999","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2007.10.010_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.bmt.1705078","article-title":"Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease","volume":"36","author":"de Lissovoy","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.010_bib20","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1182\/blood-2002-03-0984","article-title":"Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs","volume":"100","author":"Lee","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.010_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1182\/blood.V97.4.867","article-title":"Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes","volume":"97","author":"Nichols","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.010_bib22","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.V99.4.1159","article-title":"Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation","volume":"99","author":"Reusser","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.010_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1439-0507.1996.tb00123.x","article-title":"Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients","volume":"39","author":"Andstrom","year":"1996","journal-title":"Mycose.s"},{"key":"10.1016\/j.bbmt.2007.10.010_bib24","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1097\/01.tp.0000210324.44633.b1","article-title":"Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades","volume":"81","author":"Svahn","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.10.010_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bmt.1705733","article-title":"Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy","author":"Saito","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.010_bib26","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplan"},{"key":"10.1016\/j.bbmt.2007.10.010_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2007.10.010_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2007.10.010_bib29","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","article-title":"An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.010_bib30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9343(89)80606-0","article-title":"Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients","volume":"87","author":"Robbins","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2007.10.010_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7326\/0003-4819-114-2-145","article-title":"Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients","volume":"114","author":"Chao","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2007.10.010_bib32","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.bmt.1703310","article-title":"A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures","volume":"28","author":"Mishra","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.010_bib33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJM198809293191305","article-title":"Estimating physicians' work for a resource-based relative-value scale","volume":"319","author":"Hsiao","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2007.10.010_bib34","unstructured":"Bureau of Labor Statistics. Consumer Price Index. Available at http:\/\/www.bls.gov. Accessed March 1, 2005."},{"key":"10.1016\/j.bbmt.2007.10.010_bib35","series-title":"Cost-effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.bbmt.2007.10.010_bib36","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.bbmt.2007.10.010_bib37","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V104.11.730.730","article-title":"Sirolimus, tacrolimus and reduced-dose methotrexate as graft versus host disease (GVHD) prophylaxis after non-myeloablative stem cell transplantation: low incidence of acute GVHD compared with tacrolimus\/methotrexate or cyclosporine\/prednisone","volume":"104","author":"Alyea","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.010_bib38","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2003-02-0489","article-title":"Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation","volume":"102","author":"Antin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.10.010_bib39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbmt.2003.12.305","article-title":"Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation","volume":"10","author":"Cutler","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.010_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.bmt.1703641","article-title":"Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia","volume":"30","author":"van Agthoven","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.10.010_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.tp.0000226171.43943.d3","article-title":"Costs of allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Svahn","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.10.010_bib42","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.healun.2004.10.012","article-title":"A cost-effectiveness and cost-utility study of lung transplantation","volume":"24","author":"Vasiliadis","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.bbmt.2007.10.010_bib43","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1378\/chest.108.6.1594","article-title":"The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group","volume":"108","author":"Ramsey","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.bbmt.2007.10.010_bib44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1067\/mtc.2002.120342","article-title":"An economic evaluation of lung transplantation","volume":"123","author":"Anyanwu","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bbmt.2007.10.010_bib45","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1200\/JCO.1999.17.9.2811","article-title":"Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting?","volume":"17","author":"Rizzo","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.10.010_bib46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107005381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107005381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:31:29Z","timestamp":1761057089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879107005381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S1083879107005381"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.10.010","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Costs of Allogeneic Hematopoietic Cell Transplantation with High-Dose Regimens","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}